|
HS Code |
795518 |
| Generic Name | Metoclopramide Hydrochloride |
| Drug Class | Prokinetic agent |
| Brand Names | Reglan, Maxolon |
| Dosage Forms | Tablets, oral solution, injectable solution |
| Route Of Administration | Oral, intravenous, intramuscular |
| Indications | Gastroesophageal reflux disease, nausea and vomiting, gastroparesis |
| Mechanism Of Action | Dopamine D2 receptor antagonist |
| Half Life | 5 to 6 hours |
| Pregnancy Category | Category B (US) |
| Common Side Effects | Drowsiness, fatigue, restlessness, diarrhea |
| Contraindications | Pheochromocytoma, gastrointestinal hemorrhage, mechanical bowel obstruction |
| Molecular Formula | C14H23ClN2O2 |
| Storage Conditions | Store at 20°C to 25°C (68°F to 77°F) |
| Atc Code | A03FA01 |
As an accredited Metoclopramide Hydrochloride factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | White, opaque plastic bottle containing 100 tablets, labeled "Metoclopramide Hydrochloride 10 mg," with dosage details, warnings, and manufacturer information. |
| Shipping | Metoclopramide Hydrochloride should be shipped in tightly sealed containers, protected from light and moisture. It must comply with all relevant transport regulations. Typically, it is transported at ambient temperature unless otherwise specified. Proper labeling and documentation, including hazard identification, are required to ensure safe and compliant handling during shipping. |
| Storage | Metoclopramide Hydrochloride should be stored in a tightly closed container at controlled room temperature, ideally between 20°C to 25°C (68°F to 77°F), protected from light and moisture. Keep away from excess heat and incompatible substances. Store in a secure area, out of reach of children and unauthorized personnel, to ensure its stability and prevent contamination or misuse. |
|
Purity 99%: Metoclopramide Hydrochloride with purity 99% is used in the formulation of oral antiemetic solutions, where high purity ensures consistent pharmacological efficacy. Melting Point 145°C: Metoclopramide Hydrochloride at a melting point of 145°C is used in tablet manufacturing, where thermal stability during compression processes is maintained. Particle Size 10 µm: Metoclopramide Hydrochloride with a particle size of 10 µm is used in injectable preparations, where fine particle size promotes rapid dissolution and bioavailability. Stability Temperature 25°C: Metoclopramide Hydrochloride stable at 25°C is used in storage and transport environments, where chemical integrity is preserved over extended periods. Assay 98-102%: Metoclopramide Hydrochloride within an assay range of 98-102% is used in compounding hospital formulations, where precise dosing accuracy is achieved. Moisture Content ≤0.5%: Metoclopramide Hydrochloride with moisture content ≤0.5% is used in the production of immediate-release capsules, where low moisture prevents degradation and ensures product shelf-life. |
Competitive Metoclopramide Hydrochloride prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Metoclopramide Hydrochloride has carved out a solid spot in hospitals, clinics, and pharmacies worldwide. Over the years, I’ve seen physicians reach for this medication not just out of habit, but because they trust what it can do for folks struggling with persistent nausea, vomiting, or digestive sluggishness. There’s a real need for drugs that improve quality of life without clouding the mind or breaking the bank. Metoclopramide has earned its keep by ticking these boxes for a lot of patients, especially those dealing with the aftereffects of chemotherapy or chronic gastrointestinal issues.
This product, typically offered in 10 mg tablets but also found in injectable forms, works by speeding up the movement of food through the stomach and upper intestines. People dealing with conditions like gastroparesis—a slowdown of stomach emptying, often hitting those with diabetes hard—find that metoclopramide can help them eat and live with less discomfort. It’s also regularly used in cancer care to keep nausea at bay during tough treatments. There’s something reassuring about a medicine that does its job without putting patients in a mental fog, which is something I wish I saw more often.
Gastrointestinal complaints fill exam rooms and emergency departments on any given day. There are times when simply quieting an upset digestive tract lets people go home sooner, or makes life with long-term disease a bit less miserable. Metoclopramide’s action as a prokinetic—meaning it gets the gut moving—is different from drugs that only mask nausea or dull pain. That’s one reason why so many prescribers favor it for both acute episodes and chronic care, especially when other options fall short or pile on unwanted effects.
I remember talking with a man in his late forties, frustrated by months of unpredictable vomiting after starting treatment for head and neck cancer. The anti-nausea pills he’d tried either knocked him out or didn’t work long enough. He described how just being able to eat a sandwich, hold down his medication, and leave the house changed his whole outlook. For him, metoclopramide made a difference—not because it was new and shiny, but because it was dependable and didn’t come with surprises. Stories like his remind me why real-world experience matters just as much as what’s in a package insert.
Every medication has its strengths and weaknesses, and metoclopramide is no exception. You’ll typically find it prescribed in doses ranging from 5 mg to 10 mg, given three or four times a day. Doctors adjust these numbers depending on what the patient needs, how well they handle the drug, and whether they have other health issues. The injectable form usually goes into a vein or muscle when folks can’t swallow or need quick relief from severe symptoms. That flexibility stands out, especially if someone is hospitalized or can't manage pills during a rough patch.
Medications targeting nausea and vomiting aren’t all built the same. Metoclopramide works by influencing dopamine receptors in the brain and gut, which ramps up stomach muscle contractions and helps empty food more efficiently. Contrast that with older antiemetics like promethazine, which can make patients drowsy and unfocused, or steroids that carry a different list of risks. Newer drugs, such as ondansetron, operate on serotonin receptors and can cost quite a bit more, especially outside insurance plans.
The beauty of metoclopramide is its versatility—it handles not just nausea, but delayed gastric emptying and even aids in the placement of feeding tubes or radiological studies. Many patients end up taking it alongside other treatments, not instead of them. It doesn’t wipe the slate clean for everyone, and long-term use calls for careful monitoring because of possible movement disorders and other side effects. Still, in many cases, it strikes a rare balance between effectiveness and affordability.
No medication comes without risks, and it’s impossible to talk about metoclopramide without mentioning the potential for extrapyramidal symptoms—things like restlessness, muscle stiffness, or, in rare cases, tardive dyskinesia, which may stick around even after the drug’s stopped. Folks over 65 or those needing high doses for long periods sit at the biggest risk. Whenever I’ve talked with pharmacists or watched nurses at work, I’ve seen them double-checking orders and counseling patients to report anything odd about their movements or moods.
Clear communication between the care team and patient makes all the difference here. I’ve met people who assumed side effects were just “part of getting older” until a nurse pointed out the link. Education isn’t just a bonus—it’s the guardrail that keeps a useful treatment from becoming a problem.
A lot of patients start using metoclopramide in the hospital, but their needs don’t end there. Outpatient care demands quick follow-up and advice that fits into daily life. Someone relying on antiemetics at home wants more than just a bottle of pills—they seek clarity about what to watch for, how to take the medication around meals, and what to do if they feel different. I’ve watched caregivers at home grow more confident when they see a plan, not just a prescription.
Affordable access makes all the difference. Generic tablets and vials are usually covered by insurance and show up on discount pharmacy lists. This means more people can stick with their regimen without trading off groceries or rent. Healthcare is full of tough financial choices, and drugs that pay back in real symptom relief without sticker shock matter more than ever, especially for those dealing with chronic or disabling illness.
Today’s doctors face shelves full of antiemetics, each with a slightly different focus. The judgment on what to choose comes down to the patient in front of you—their story, their history, and what’s affordable. Some might wonder why we still use medications that have been around for decades when there are always newer, more expensive options waiting in the wings. The answer isn’t nostalgia; it’s the consistent results metoclopramide offers, especially for everyday needs that aren’t about the latest breakthrough but about staying steady through week after week of treatment.
Working with patients from all walks of life, I’ve learned the importance of flexibility. Metoclopramide comes as tablets, dissolvable formulas, and injections. That variety helps when someone can’t swallow due to surgery or treatments, or in emergencies where time matters. I recall a teenager in the ER with relentless vomiting—a few minutes after a metoclopramide injection, she could sip water again. For others, the tablet fits right into their morning routine at home. These small victories—eating a meal, keeping a medicine down—pile up and help people get through daily challenges.
This kind of practicality sets metoclopramide apart from drugs that need special handling or carry high out-of-pocket costs. It’s a workhorse, not a showhorse, and sometimes that’s exactly what is needed to steady a patient enough to focus on other parts of healing.
Doctors and pharmacists keep a careful eye out for early signs of trouble with long-term use. Health agencies have issued guidance about using metoclopramide for only as long as needed and switching to alternatives if problems arise. People who need ongoing support should expect regular check-ins, not just a one-time prescription. Even with side effects in the conversation, for many patients the benefits on tough days tip the scale in favor of giving it a try under careful supervision.
I’ve watched oncology nurses juggle symptom control, looking for that sweet spot where relief comes with minimal risk. They balance the competing forces of comfort, cost, and safety, leaning on collective experience and new evidence to guide each choice. Medications that stand the test of time in these settings do so because they earn trust, not because no alternatives exist.
Metoclopramide’s presence in both primary care clinics and specialist practices says something about its value. In one gastroenterology office, a young woman recounted the frustration of eating a meal and feeling it “sit like a brick” in her stomach for hours. She’d cycled through various diets and supplements before her doctor recommended a trial of metoclopramide. Within weeks, she found eating less stressful, allowing her to build up strength and focus on life beyond her symptoms.
The medication also supports patients in the tough early stages of pregnancy, when severe nausea and vomiting threaten nutrition and wellbeing. Though safe use in pregnancy requires careful attention, the knowledge that a tried-and-true option exists can calm fears and give hope to people struggling through difficult months.
When talking with patients about metoclopramide, honesty about both benefits and risks lays the groundwork for trust. People appreciate plain language: what the medicine aims to accomplish, how to take it, and what red flags to watch for down the road. Shared decision-making stands at the center of good care, especially for drugs where side effects may show up after weeks or months. Every person’s experience shapes the decision to start, stay on, or stop the medicine.
I’ve seen this firsthand as healthcare providers adjust treatment in response to feedback. A partnership based on real-time information, rather than rigid routines, keeps care personalized and often safer.
Medical practice doesn’t stand still. Decades of clinical studies, patient reports, and professional reflection have built a solid foundation for metoclopramide’s use. Its listing on the World Health Organization’s Model List of Essential Medicines reflects broad agreement on its usefulness in a wide range of settings, from rural clinics to top-tier hospitals.
Despite shifting guidelines and periodic caution about side effects, this medication continues to earn a spot in treatment protocols for everything from diabetic gastroparesis to chemotherapy-induced nausea. National and international health organizations point to the strength of evidence for short-term relief, especially when other therapies either fall short or carry unacceptable risk or cost.
That consensus doesn’t erase the need for vigilance, especially as more patients with complex medical histories turn to this drug. Modern prescribing often includes genetic or metabolic testing, greater attention to drug interactions, and careful follow-up through virtual or in-person visits.
Side effects and long-term risks demand solutions beyond careful prescribing. Healthcare teams now offer more comprehensive education, use clinical decision tools to spot risky combinations, and make it easier to report new or worsening symptoms. Some clinics flag high-risk patients for special follow-up, while pharmacies employ checks to catch potential overuse.
Digital health records have helped in spotting patterns that call for change. By connecting the dots between symptoms and prescribing history, care teams act sooner to switch strategies or add supports. These small shifts in workflow can reduce harm and build confidence among patients who may arrive at the pharmacy anxious about what’s next.
Medical societies continue to update recommendations based on fresh research and real-world reports. The goal is always the same: match the medication to the patient in a way that balances relief, safety, and sustainability across long stretches—not just for a few days. This iterative approach gives me hope that tools like metoclopramide will remain useful, relevant, and accessible well into the future.
Cost weighs heavily on the minds of patients and clinicians alike. Unlike newer, brand-only treatments, metoclopramide has a long generic history, lowering barriers for those without comprehensive insurance. I’ve met families where every prescription becomes a budgetary trade-off, and programs that close that gap can make the difference between hope and resignation.
Local pharmacies, community clinics, and nonprofit health organizations often lean on medications like this to keep care affordable. Their staff work hard to connect patients with resources, find lower-priced options, or structure therapy that respects not just the science but the lived reality of paying for medicine month-in and month-out.
Metoclopramide Hydrochloride stands as a testament to the power of familiarity combined with clinical evidence. It doesn’t promise miracles, but it’s earned a reputation for dependability where it’s needed, especially in treating tough or ongoing nausea and gastrointestinal troubles. Its flexibility, affordability, and proven effect set it apart in a crowded field. As medicine continues to evolve, there’s room for both innovation and respect for workhorses like this one. Patients, families, and practitioners alike benefit when decisions are grounded in experience, facts, and clear-eyed conversation about risks and rewards.